Hermetica Superfood Encyclopedia
The Short Answer
Epimedin A is a flavonoid glycoside derived from Epimedium species that promotes bone formation by enhancing osteoblast differentiation and proliferation. This bioactive compound inhibits bone-resorbing osteoclasts through the TRAF6/PI3K/AKT/NF-κB signaling pathway.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary KeywordEpimedin A benefits
Synergy Pairings3
Epimedin A (Flavonoid Glycoside) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Epimedin A is a flavonoid glycoside isolated from Epimedium species (horny goat weed), a plant used in traditional Chinese medicine. It is extracted from the aerial parts of Epimedium plants using ethanol extraction followed by purification, typically as part of epimedium total flavonoids (ETF).
“Epimedin A is a component of Epimedium (Yin Yang Huo), used in traditional Chinese medicine for over 2,000 years to treat bone disorders, kidney yang deficiency, fatigue, and impotence. Modern research has focused on its traditional use for osteoporosis and bone health.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses on Epimedin A were identified. Evidence is limited to preclinical studies including in vitro osteoblast assays and ovariectomized rat models showing dose-dependent improvements in bone parameters over 3-month interventions, though specific sample sizes and doses were not reported.
Preparation & Dosage
Traditional preparation
No clinically studied human dosages available. In vitro studies used 0.1-0.4 μM concentrations on RAW264.7 cells for 5 days. Rat studies involved 3-month oral administration with dose-dependent effects, but specific mg/kg ranges were not detailed. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Epimedin A is a purified flavonoid glycoside compound (C38H48O20, molecular weight ~840.8 g/mol), not a whole food ingredient, and therefore carries no macronutrient, fiber, or caloric profile. It is a prenylflavonol glycoside — specifically an 8-prenylkaempferol derivative bearing three sugar moieties (two rhamnosyl units and one xylosyl unit) attached at the 3-position of the flavonol backbone. As a bioactive compound, its relevant 'profile' is characterized by its phytochemical composition: the core aglycone is icaritin (a prenylated flavonol), which is released upon metabolic deglycosylation in the gut. Epimedin A is one of four primary icariin-type flavonoids found in Epimedium species (alongside Epimedin B, Epimedin C, and icariin), and typically constitutes approximately 2–8% of total flavonoid content in standardized Epimedium extracts depending on species and plant part. Bioavailability is limited when the compound is taken orally in glycoside form; intestinal and hepatic enzymatic hydrolysis (by β-glycosidases and gut microbiota) converts it to more absorbable aglycone metabolites including icaritin and desmethylicaritin. Oral bioavailability of intact Epimedin A is low (estimated <10% in rodent models), with peak plasma concentrations of metabolites observed at 1–3 hours post-ingestion. No vitamin, mineral, or protein content is applicable. The compound contains multiple phenolic hydroxyl groups contributing to antioxidant capacity, and the prenyl side chain is considered critical for its osteogenic and estrogenic receptor-binding activity.
How It Works
Mechanism of Action
Epimedin A enhances osteoblast differentiation and proliferation through direct cellular stimulation, promoting bone matrix formation and mineralization. The compound simultaneously inhibits osteoclast formation by disrupting the TRAF6/PI3K/AKT/NF-κB signaling cascade, reducing bone resorption. This dual mechanism targets both bone formation and bone breakdown processes at the molecular level.
Clinical Evidence
Current evidence for Epimedin A comes primarily from in vitro cellular studies demonstrating enhanced osteoblast activity and differentiation. Animal studies in ovariectomized rats showed increased bone density and volume following 3-month oral interventions, though specific dosages and sample sizes were not provided in the available data. Human clinical trials evaluating Epimedin A's bone health effects are currently lacking. The evidence remains preliminary and requires human studies to establish clinical efficacy and optimal dosing protocols.
Safety & Interactions
Safety data for isolated Epimedin A supplementation is limited, as most research focuses on whole Epimedium extracts containing multiple compounds. Potential interactions with hormone replacement therapy and bone medications like bisphosphonates are theoretically possible due to overlapping bone metabolism pathways. Pregnant and breastfeeding women should avoid Epimedin A due to insufficient safety data and potential hormonal effects. Individuals with hormone-sensitive conditions should consult healthcare providers before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
(2S)-2-[4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxyphenyl]-5,7-dihydroxychroman-4-oneEMAIcariin IIHorny Goat Weed FlavonoidYin Yang Huo GlycosideEpimedium Flavonoid A
Frequently Asked Questions
What is the difference between Epimedin A and icariin?
Epimedin A and icariin are both flavonoid glycosides from Epimedium plants, but they have different molecular structures and bioactivities. Icariin is more extensively studied and has broader applications, while Epimedin A shows more specific bone-protective effects through distinct cellular pathways.
How much Epimedin A should I take for bone health?
No established human dosage exists for Epimedin A supplementation, as clinical trials have not been conducted. Animal studies used varying doses over 3-month periods, but these cannot be directly translated to human recommendations without proper clinical research.
Can Epimedin A help with osteoporosis?
Epimedin A shows promise for bone health in laboratory and animal studies by increasing bone density and reducing bone loss. However, human clinical trials are needed to determine if these effects translate to osteoporosis prevention or treatment in people.
What foods contain Epimedin A naturally?
Epimedin A occurs naturally in Epimedium species plants, commonly known as horny goat weed or barrenwort. These plants are not typically consumed as food but are used in traditional herbal preparations, with Epimedin A requiring extraction and purification for supplemental use.
Does Epimedin A have side effects?
Specific side effects of isolated Epimedin A are not well documented due to limited human studies. Potential concerns include hormonal effects and interactions with bone medications, though comprehensive safety profiles require further clinical investigation.
What is the evidence quality for Epimedin A's effects on bone health in humans?
Current evidence for Epimedin A is limited primarily to in vitro studies and animal models, particularly ovariectomized rat studies lasting 3 months. While these studies demonstrate promising mechanisms—such as enhanced osteoblast differentiation and inhibition of osteoclast formation via the TRAF6/PI3K/AKT/NF-κB pathway—human clinical trials remain absent or very limited. More rigorous, long-term human studies are needed to confirm whether these bone-building effects translate to meaningful clinical outcomes in people.
Is Epimedin A safe for pregnant women or children?
Specific safety data for Epimedin A in pregnant women and children is not well-established in the scientific literature. Most safety assessments come from animal studies and traditional use in herbal preparations, rather than dedicated human trials in these populations. It is advisable to consult a healthcare provider before using Epimedin A supplements during pregnancy or in pediatric populations due to the lack of targeted safety evidence.
How does Epimedin A bioavailability compare across different supplement forms?
Limited research directly compares bioavailability of Epimedin A across different forms (powder, extract, standardized formulations, etc.), though flavonoid glycosides in general benefit from consumption with fats and certain food components that may enhance absorption. Most commercial supplements standardize Epimedin A content from Epimedium plant extracts, but absorption variability depends on individual factors like gut health and the presence of food. Choosing standardized extracts with documented Epimedin A content may offer more consistent delivery than whole-plant preparations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w epimedin-a curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
